.Merck beats revenues requirements, increases sales overview on powerful need for best medications like Keytruda CNBCMerck & Co. (MRK United States) Beats Earnings Estimates as Keytruda Sales Rise BloombergMerck Inventory: Pharma Titan Posts Sturdy End Results, Yet Expectation Tumbles Short Investor's Company DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats earnings as well as purchases desires amid Keytruda asset, but provides blended full-year expectation MarketWatch.